| Business Summary | | BIOQUAL,
Inc.
provides
research,
development
and
consulting
services
to
government
and
commercial
contract
clients.
The
Company
specializes
in
life
sciences
research
involving
the
utilization
of
animal
models.
The
Company
also
develops
and
markets
veterinary
medical
products.
Currently,
the
Company
is
organized
into
five
divisions
reflecting
various
research
focuses:
Division
of
Primate
Biology
and
Medicine,
Division
of
Laboratory
Animal
Sciences,
Division
of
Reproductive
Endocrinology
and
Toxicology,
Division
of
Bioresearch
and
the
Division
of
Neurobiology
and
Behavior. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | BIOQUAL,
Inc.
develops,
produces
and
sells
diagnostic
test
kits
incorporating
monoclonal
antibodies
to
diagnose
certain
anemias,
infections,
and
parasitic
diseases.
For
the
fiscal
year
ended
5/31/01,
total
revenues
increased
5%
to
$12.3
million.
Net
income
totalled
$285
thousand,
up
from
$97
thousand.
Revenues
benefited
from
increased
government
contract
activity.
Net
income
also
reflects
a
voluntary
reduction
in
staffing
at
the
Company's
Department
of
Discovery
Research. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| John Landon, Ph.D., 63 Chairman,
Pres, CEO | $338K | -- | David Newcomer, 39 CFO | 116K | $1.7K | Michael O'Flaherty, 62 COO
and Sec. | 180K | 14.6K | Richard Bradbury, 65 VP | 116K | 2.2K | Leanne DeNenno, 46 VP | -- | -- | Dollar amounts are as of 31-May-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|